FDA advisory committee calendar
This page lists 2 FDA advisory committee meetings covering July 2026. 2 have taken a vote, and the vote count is shown. An advisory committee vote is a recommendation to the FDA, which is not bound by it and has gone against it before.
Upcoming FDA advisory committee (AdComm) meetings that review biotech drugs and biologics, the panel vote that often moves the stock more than the PDUFA itself. Sourced from FDA Federal Register notices. Meetings are announced ~4-6 weeks ahead, so this fills in as the FDA schedules them.
Meetings & results
Companies on this page
Questions
What is an FDA advisory committee?
A panel of outside experts convened to review an application's evidence and vote on questions the FDA poses.
Is the FDA bound by the vote?
No. The vote is advisory; the FDA usually follows it but is free not to.
How many meetings are on record here?
2 advisory committee meetings are documented with their votes and outcomes as of August 24, 2026.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent publication with no affiliation with, endorsement by, sponsorship by, or connection to the U.S. Food and Drug Administration or any other government agency. “FDA”, “PDUFA” and all company, drug and ticker names are used descriptively and remain the property of their respective owners.
Informational and educational purposes only. Not investment advice. Nothing on this page is investment, legal, tax or medical advice, or an offer or solicitation to buy or sell any security. pdufa.bio is not a registered investment adviser or broker-dealer and does not recommend trades or publish individual-drug approval probabilities. Verify every date and outcome against primary FDA, SEC or company filings. Data is provided as is, without warranty of any kind, and past behaviour does not predict future outcomes.
© 2026 pdufa.bio. All rights reserved.